Subscribe
istock-652532896_filograph
filograph / iStockphoto.com
3 July 2018Big Pharma

Novartis launches Nerve platform to harness ‘data revolution’

Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Sanofi to launch €66m R&D hub in China
5 July 2018   France-based Sanofi has announced plans to launch a research and development hub in China to focus on digitalisation and big data analysis.
Americas
Novartis sells portions of Sandoz US portfolio to Aurobindo
6 September 2018   Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Americas
Novartis sells portions of Sandoz US portfolio to Aurobindo
6 September 2018   Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million.
Asia-Pacific
Sanofi to launch €66m R&D hub in China
5 July 2018   France-based Sanofi has announced plans to launch a research and development hub in China to focus on digitalisation and big data analysis.

More on this story

Americas
Novartis sells portions of Sandoz US portfolio to Aurobindo
6 September 2018   Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million.
Asia-Pacific
Sanofi to launch €66m R&D hub in China
5 July 2018   France-based Sanofi has announced plans to launch a research and development hub in China to focus on digitalisation and big data analysis.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent